Neratinib is a TFEB and TFE3 activator that potentiates autophagy and unbalances energy metabolism in ERBB2+breast cancer cells

Bellese, G; Tagliatti, E; Gagliani, MC; Santamaria, S; Arnaldi, P; Falletta, P; Rusmini, P; Matteoli, M; Castagnola, P; Cortese, K

Cortese, K (通讯作者)，Univ Genoa, Dept Expt Med, Cellular Electron Microscopy Lab, DIMES, Genoa, Italy.;Castagnola, P (通讯作者)，IRCCS Osped Policlin San Martino, Genoa, Italy.

BIOCHEMICAL PHARMACOLOGY, 2023; 213 ():

Abstract

Neratinib (NE) is an irreversible pan-ERBB tyrosine kinase inhibitor used to treat breast cancers (BCa) with amplification of the ERBB2/HER2/Neu gene ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索